Please check your internet connection and try again.
# Sompraz HP (Esomeprazole)
## Overview
Sompraz HP is a combination product containing esomeprazole, a proton pump inhibitor (PPI), and amoxicillin and clarithromycin, antibiotics. It is used for the eradication of *Helicobacter pylori* infection.
## Primary Indications
* Eradication of *Helicobacter pylori* infection in patients with peptic ulcer disease.
## Adult Dosing
* **Sompraz HP:** One dose pack taken twice daily for 10 days. Each dose pack contains:
* Esomeprazole 20 mg
* Amoxicillin 1000 mg
* Clarithromycin 500 mg
## Pediatric Dosing
* The safety and efficacy of Sompraz HP in pediatric patients have not been established. Dosing for pediatric *H. pylori* eradication typically involves weight-based regimens for the individual components, and specific combinations should be guided by local protocols and specialist consultation.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment is typically recommended for amoxicillin or clarithromycin in mild to moderate renal impairment. Severe impairment may require dose adjustment. Esomeprazole generally does not require dose adjustment.
* **Hepatic Impairment:**
* Esomeprazole: Use with caution; a reduced dose may be considered.
* Clarithromycin: Dose reduction may be necessary in moderate to severe hepatic impairment.
* Amoxicillin: No dose adjustment typically needed.
* Dosing may need to be adjusted based on local antimicrobial resistance patterns and patient factors.
## Contraindications
* Hypersensitivity to esomeprazole, amoxicillin, clarithromycin, other macrolides, or penicillins.
* History of hypersensitivity to penicillin or cephalosporin antibiotics.
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Concomitant use of ergotamine or dihydroergotamine.
* Severe renal impairment with concomitant use of clarithromycin and other drugs that prolong the QT interval.
* Electrolyte abnormalities (e.g., hypokalemia, hypomagnesemia).
## Adverse Effects
* **Common:** Diarrhea, nausea, abdominal pain, headache, taste perversion, rash.
* **Serious:** *Clostridium difficile*-associated diarrhea, anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis, QT prolongation, hepatotoxicity, interstitial nephritis.
## Key Drug Interactions
* **Esomeprazole:** Affects absorption of drugs requiring acidic gastric pH (e.g., ketoconazole, itraconazole, certain HIV protease inhibitors). May increase levels of drugs metabolized by CYP2C19 (e.g., warfarin, diazepam) or CYP3A4 (e.g., some calcium channel blockers).
* **Clarithromycin:** Potent CYP3A4 inhibitor. Significantly increases levels of numerous drugs (e.g., carbamazepine, cyclosporine, digoxin, simvastatin, lovastatin, colchicine, ergot alkaloids, certain calcium channel blockers, sildenafil, theophylline, triazolam, midazolam). Increases QT interval in conjunction with other QT-prolonging drugs.
* **Amoxicillin:** May decrease the efficacy of oral contraceptives. Probenecid may decrease renal excretion.
## Monitoring
* Signs and symptoms of *H. pylori* eradication.
* Liver function tests, especially in patients with hepatic impairment.
* Renal function.
* Signs of hypersensitivity reactions.
* Signs of *C. difficile* infection.
## Clinical Pearls
* This combination therapy is designed for a specific duration of treatment to maximize eradication rates.
* Ensure patients complete the full course of antibiotics, even if symptoms improve.
* Counsel patients on potential side effects, including diarrhea and the importance of reporting severe or persistent symptoms.
* Due to the broad-spectrum nature and potential for resistance, stewardship principles should be applied.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant literature for complete details, including indications, contraindications, warnings, precautions, adverse reactions, and drug interactions, before making any clinical decisions. Local guidelines and protocols may vary.
